1. Home
  2. ACHV vs NNY Comparison

ACHV vs NNY Comparison

Compare ACHV & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • NNY
  • Stock Information
  • Founded
  • ACHV N/A
  • NNY 1987
  • Country
  • ACHV United States
  • NNY United States
  • Employees
  • ACHV N/A
  • NNY N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NNY Investment Managers
  • Sector
  • ACHV Health Care
  • NNY Finance
  • Exchange
  • ACHV Nasdaq
  • NNY Nasdaq
  • Market Cap
  • ACHV 131.2M
  • NNY 153.2M
  • IPO Year
  • ACHV N/A
  • NNY N/A
  • Fundamental
  • Price
  • ACHV $2.55
  • NNY $8.06
  • Analyst Decision
  • ACHV Strong Buy
  • NNY
  • Analyst Count
  • ACHV 3
  • NNY 0
  • Target Price
  • ACHV $14.33
  • NNY N/A
  • AVG Volume (30 Days)
  • ACHV 652.7K
  • NNY 50.9K
  • Earning Date
  • ACHV 08-07-2025
  • NNY 01-01-0001
  • Dividend Yield
  • ACHV N/A
  • NNY 4.04%
  • EPS Growth
  • ACHV N/A
  • NNY N/A
  • EPS
  • ACHV N/A
  • NNY N/A
  • Revenue
  • ACHV N/A
  • NNY N/A
  • Revenue This Year
  • ACHV N/A
  • NNY N/A
  • Revenue Next Year
  • ACHV N/A
  • NNY N/A
  • P/E Ratio
  • ACHV N/A
  • NNY N/A
  • Revenue Growth
  • ACHV N/A
  • NNY N/A
  • 52 Week Low
  • ACHV $1.84
  • NNY $7.58
  • 52 Week High
  • ACHV $5.31
  • NNY $8.87
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 46.32
  • NNY 47.30
  • Support Level
  • ACHV $2.37
  • NNY $8.07
  • Resistance Level
  • ACHV $2.56
  • NNY $8.24
  • Average True Range (ATR)
  • ACHV 0.12
  • NNY 0.10
  • MACD
  • ACHV 0.01
  • NNY 0.00
  • Stochastic Oscillator
  • ACHV 47.37
  • NNY 26.09

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About NNY Nuveen New York Municipal Value Fund

Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.

Share on Social Networks: